EVE Total Operating Expenses vs Selling General Administrative Analysis
EVE Stock | 0 0.00 0.00% |
EVE Health financial indicator trend analysis is much more than just examining EVE Health Group latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EVE Health Group is a good investment. Please check the relationship between EVE Health Total Operating Expenses and its Selling General Administrative accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Total Operating Expenses vs Selling General Administrative
Total Operating Expenses vs Selling General Administrative Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EVE Health Group Total Operating Expenses account and Selling General Administrative. At this time, the significance of the direction appears to have no relationship.
The correlation between EVE Health's Total Operating Expenses and Selling General Administrative is 0.0. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of EVE Health Group, assuming nothing else is changed. The correlation between historical values of EVE Health's Total Operating Expenses and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of EVE Health Group are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Total Operating Expenses i.e., EVE Health's Total Operating Expenses and Selling General Administrative go up and down completely randomly.
Correlation Coefficient | 0.0 |
Relationship Direction | Flat |
Relationship Strength | Insignificant |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Selling General Administrative
Most indicators from EVE Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EVE Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EVE Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to drop to about 625.9 K in 2024. Discontinued Operations is likely to drop to about (2 M) in 2024
EVE Health fundamental ratios Correlations
Click cells to compare fundamentals
EVE Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EVE Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.1M | 11.9M | 8.1M | 4.1M | 2.5M | 2.4M | |
Short Long Term Debt Total | 584.3K | 1.0M | 492.4K | 4.3K | 74.9K | 71.1K | |
Other Current Liab | 131.2K | 289.7K | 309.0K | 750.6K | 959.4K | 1.0M | |
Total Current Liabilities | 581.8K | 951.5K | 743.1K | 1.0M | 1.3M | 656.0K | |
Total Stockholder Equity | 13.0M | 10.2M | 6.9M | 3.1M | 1.2M | 1.2M | |
Net Debt | (4.6M) | (2.1M) | (610.0K) | (188.2K) | (31.3K) | (32.9K) | |
Retained Earnings | (20.3M) | (23.8M) | (29.1M) | (33.1M) | (34.8M) | (33.1M) | |
Accounts Payable | 404.8K | 431.5K | 338.4K | 254.2K | 264.8K | 295.4K | |
Cash | 5.1M | 3.2M | 1.1M | 192.5K | 106.2K | 100.9K | |
Non Current Assets Total | 7.3M | 7.2M | 5.4M | 13.2K | 179.0 | 170.05 | |
Non Currrent Assets Other | (217.5K) | (6.9M) | (6.9M) | (5.0M) | (13.2K) | 0.0 | |
Cash And Short Term Investments | 5.1M | 3.2M | 1.1M | 192.5K | 106.2K | 100.9K | |
Net Receivables | 923.5K | 352.4K | 250.7K | 115.7K | 78.7K | 74.8K | |
Common Stock Shares Outstanding | 3.7B | 4.6B | 4.0B | 5.2B | 5.3B | 5.5B | |
Liabilities And Stockholders Equity | 14.1M | 11.9M | 8.1M | 4.1M | 2.5M | 2.4M | |
Non Current Liabilities Total | 76.8K | 722.7K | 538.5K | 784.6K | 396.6K | 0.0 | |
Other Stockholder Equity | (14.8M) | (12.0M) | (8.8M) | (5.0M) | (4.5M) | (4.7M) | |
Total Liab | 1.1M | 1.7M | 1.1M | 1.0M | 1.3M | 835.7K | |
Total Current Assets | 6.8M | 4.7M | 2.7M | 4.1M | 2.5M | 2.8M | |
Accumulated Other Comprehensive Income | 297.5K | 343.3K | 415.3K | 431.9K | 194.0K | 184.3K | |
Common Stock | 33.0M | 33.6M | 35.6M | 35.8M | 41.2M | 43.3M | |
Short Term Debt | 45.8K | 230.3K | 95.7K | 4.3K | 74.9K | 71.1K | |
Property Plant And Equipment Net | 4.8M | 5.2M | 4.5M | 13.2K | 179.0 | 170.05 | |
Property Plant And Equipment Gross | 4.8M | 5.7M | 5.2M | 26.5K | 179.0 | 170.05 | |
Property Plant Equipment | 4.8M | 5.2M | 4.5M | 11.1K | 10.0K | 9.5K | |
Other Current Assets | 303.3K | 202.6K | 201.5K | 3.3M | 2.2M | 2.3M | |
Inventory | 766.6K | 1.2M | 1.4M | 522.9K | 141.5K | 134.5K | |
Net Tangible Assets | 12.0M | 9.3M | 6.8M | 3.1M | 3.6M | 6.4M | |
Long Term Investments | 1.8M | 1.2M | 701.0K | 359.9K | 323.9K | 307.7K | |
Net Invested Capital | 13.5M | 10.7M | 7.4M | 4.6M | 1.3M | 1.2M | |
Cash And Equivalents | 340.3K | 5.1M | 3.2M | 1.1M | 1.3M | 1.2M | |
Net Working Capital | 6.2M | 3.7M | 2.0M | 4.1M | 1.2M | 1.2M | |
Current Deferred Revenue | (45.8K) | (230.3K) | (95.7K) | (1.0) | 326K | 342.3K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EVE Stock Analysis
When running EVE Health's price analysis, check to measure EVE Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVE Health is operating at the current time. Most of EVE Health's value examination focuses on studying past and present price action to predict the probability of EVE Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EVE Health's price. Additionally, you may evaluate how the addition of EVE Health to your portfolios can decrease your overall portfolio volatility.